These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 25933235)

  • 1. Organizational profile: UK regenerative medicine platform immunomodulation hub.
    Asante CO
    Regen Med; 2015; 10(3):259-63. PubMed ID: 25933235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Institutional profile. The International Society for Cellular Therapy: evolving to meet the demands of the regenerative medicine industry.
    Maziarz RT; Arthurs J; Horwitz E
    Regen Med; 2011 Mar; 6(2):163-6. PubMed ID: 21391849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging Translation of Regenerative Therapies.
    Allickson JG
    Clin Pharmacol Ther; 2017 Jan; 101(1):28-30. PubMed ID: 27806427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CellCAN: a unique enabler of regenerative medicine and cell therapy in Canada.
    Roy DC; Alarco AM; Isasi R
    Stem Cells Dev; 2014 Dec; 23 Suppl 1():24-8. PubMed ID: 25457957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparing regenerative therapies for clinical application: proposals for responsible translation.
    Shapiro SA; Smith CG; Arthurs JR; Master Z
    Regen Med; 2019 Feb; 14(2):77-84. PubMed ID: 30651044
    [No Abstract]   [Full Text] [Related]  

  • 6. Regenerative medicine: future impact on clinical therapies and society.
    Kargul J; Laurent GJ; Irminger-Finger I
    Int J Biochem Cell Biol; 2014 Nov; 56():1. PubMed ID: 25461768
    [No Abstract]   [Full Text] [Related]  

  • 7. Regulating cell-based regenerative medicine: the challenges ahead.
    Ali RR; Hollander AP; Kemp P; Webster A; Wilkins MR
    Regen Med; 2014 Jan; 9(1):81-7. PubMed ID: 24351008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell therapy, 3D culture systems and tissue engineering for cardiac regeneration.
    Emmert MY; Hitchcock RW; Hoerstrup SP
    Adv Drug Deliv Rev; 2014 Apr; 69-70():254-69. PubMed ID: 24378579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Regulatory science research to facilitate the development of cell/tissue-processed products].
    Sato Y; Tsutsumi H; Sawada R; Suzuki T; Yasuda S
    Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 2013; (131):16-9. PubMed ID: 24340665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential Therapeutic Strategies of Regenerative Medicine for Renal Failure.
    Mata-Miranda MM; Delgado-Macuil RJ; Rojas-Lopez M; Martinez-Flores R; Vazquez-Zapien GJ
    Curr Stem Cell Res Ther; 2017; 12(5):423-431. PubMed ID: 28322169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regenerative medicine, resource and regulation: lessons learned from the remedi project.
    Ginty PJ; Rayment EA; Hourd P; Williams DJ
    Regen Med; 2011 Mar; 6(2):241-53. PubMed ID: 21391857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-based therapies for the preterm infant.
    Zhu D; Wallace EM; Lim R
    Cytotherapy; 2014 Dec; 16(12):1614-28. PubMed ID: 25154811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regenerative medicine strategies.
    Atala A
    J Pediatr Surg; 2012 Jan; 47(1):17-28. PubMed ID: 22244387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proceedings of the signature series event of the international society for cellular therapy: "Advancements in cellular therapies and regenerative medicine in digestive diseases," London, United Kingdom, May 3, 2017.
    Ciccocioppo R; Dos Santos CC; Baumgart DC; Cangemi GC; Cardinale V; Ciacci C; De Coppi P; Haldar D; Klersy C; Nostro MC; Ott M; Piemonti L; Tomei AA; Uygun B; Vetrano S; Orlando G
    Cytotherapy; 2018 Mar; 20(3):461-476. PubMed ID: 29398624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small molecules and small molecule drugs in regenerative medicine.
    Lu B; Atala A
    Drug Discov Today; 2014 Jun; 19(6):801-8. PubMed ID: 24252867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Manufacturing challenges in regenerative medicine.
    Martin I; Simmons PJ; Williams DF
    Sci Transl Med; 2014 Apr; 6(232):232fs16. PubMed ID: 24739757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Artificial intelligence: A joint narrative on potential use in pediatric stem and immune cell therapies and regenerative medicine.
    Sniecinski I; Seghatchian J
    Transfus Apher Sci; 2018 Jun; 57(3):422-424. PubMed ID: 29784537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver regenerative medicine: advances and challenges.
    Chistiakov DA
    Cells Tissues Organs; 2012; 196(4):291-312. PubMed ID: 22572238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stem cells: Immunology and immunomodulation.
    Tena A; Sachs DH
    Dev Ophthalmol; 2014; 53():122-32. PubMed ID: 24732766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stem cells have the potential to rejuvenate regenerative medicine research.
    Eve DJ; Fillmore R; Borlongan CV; Sanberg PR
    Med Sci Monit; 2010 Oct; 16(10):RA197-217. PubMed ID: 20885363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.